Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Tissue Plasminogen Activator for Acute Ischemic Stroke

Abstract

Background Thrombolytic therapy for acute ischemic stroke has been approached cautiously because there were high rates of intracerebral hemorrhage in early clinical trials. We performed a randomized, double-blind trial of intravenous recombinant tissue plasminogen activator (t-PA) for ischemic stroke after recent pilot studies suggested that t-PA was beneficial when treatment was begun within three hours of the onset of stroke. Methods The trial had two parts. Part 1 (in which 291 patients were enrolled) tested whether t-PA had clinical activity, as indicated by an improvement of 4 points over base-line values in the score of the National Institutes of Health stroke scale (NIHSS) or the resolution of the neurologic deficit within 24 hours of the onset of stroke. Part 2 (in which 333 patients were enrolled) used a global test statistic to assess clinical outcome at three months, according to scores on the Barthel index, modified Rankin scale, Glasgow outcome scale, and NIHSS: Results In part 1, there was no significant difference between the group given t-PA and that given placebo in the percentages of patients with neurologic improvement at 24 hours, although a benefit was observed for the t-PA group at three months for all four outcome measures. In part 2, the long-term clinical benefit of t-PA predicted by the results of part 1 was confirmed (global odds ratio for a favorable outcome, 1.7; 95 percent confidence interval, 1.2 to 2.6). As compared with patients given placebo,…

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199512143332401

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 27 references

Research works printed but not linked: 3

  1. Mahoney FI, 1965, Md State Med J, 14, 61
  2. Lyden PD, Broderick J, Mascha E. Reliability of the Barthel Index used for the NINDS t-PA Stroke Trial. In: Yamaguchi T, Mori E, Minematsuk K, del Zoppo GJ, eds. Thrombolytic therapy in acute stroke III. Tokyo, Japan: Springer-Verlag (in press).
  3. 10.1001/jama.274.13.1017 · doi:10.1001/jama.274.13.1017 · Paper page

Cited by

See all 11,654

Metadata

Authors
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Affiliations
National Institute of Neurological Disorders and Stroke (US)
Corresponding author
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Venue
New England Journal of Medicine
Published
1995-12-14
Volume
333
Issue
24
Pages
1581-1588
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2292308933
Cited by
11,654
References
27
Citations by year
2026: 192 · 2025: 290 · 2024: 348 · 2023: 314 · 2022: 355 · 2021: 475 · 2020: 389 · 2019: 425 · 2018: 407 · 2017: 445 · 2016: 410 · 2015: 530 · 2014: 500 · 2013: 569 · 2012: 590
FWCI
154.73
Type
journal article
Language
en
Open access
closed
Locations
New England Journal of Medicine (publishedVersion)
Funders
National Institute of Neurological Disorders and Stroke (N01-NS-02377, N01-NS02382, N01 NS-02374)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
tissue plasminogen activator, acute ischemic stroke, thrombolysis, intravenous tPA, intracerebral hemorrhage, treatment timing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tissue Plasminogen Activator for Acute Ischemic Stroke. https://app.cochat.ai/papers/10.1056/nejm199512143332401
The paper
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995). Tissue Plasminogen Activator for Acute Ischemic Stroke. New England Journal of Medicine. https://doi.org/10.1056/nejm199512143332401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.